Our Newest Tests
People who do not respond to aspirin are more than three times more likely to die of cardiovascular disease than those who respond well to aspirin. Our newest test, AspirinWorks® determines if aspirin is working to prevent cardiovascular events. AsprinWorks® (11-Dehydro Thromboxane B2 ELISA) is a simple urine test that determines the effect of aspirin on platelets by measuring the level of thromboxane production (aspirin’s target). The higher the levels of thromboxane, the stickier the blood platelets, and the less impact the aspirin is having. This crucial information allows physicians to individualize a patient’s therapy. Unlike other tests, which require freshly drawn blood that must be evaluated within at least four hours, the test only requires a urine sample that can be obtained in any doctor’s office, making the test easy for both physician and patient.
In addition we offer a range of new tests below:
- CA-125
- Complement 3 (C3)
- Clinical Chemistry
- Complement 4 (C4)
- Hematology/Urinalysis
- Immunoglobulin G (IgG)
- Immunoglobulin A (IgA)
- Immunoglobulin M (IgM)
- Free Testosterone (male only)
- Glucose-6-phosphate dehydrogenase deficiency (G6PD)
- 25-hydroxy Vitamin D
- Aspirin (11-dehydro-thromboxane B2)
For specimen collection requirements, please contact Client Services at (714) 657-7369.